VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
RARE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
RAREUltragenyx Pharmaceutical Inc.
$15.43$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksRAREPrice History

RARE logoUltragenyx Pharmaceutical Inc. (RARE) Stock Price History

Historical prices from 2014 to 2026

$15.43-0.14  (-0.90%)close Nov 6
Returns
1M
+6.7%
3M
-40.2%
YTD
-34.6%
1Y
-50.1%
3Y
-25.8%
5Y
-28.5%
ATH$179.65Dec 2020-91.4%
ATL$12.73Sep 2026pre-split
Avg Vol (50D)5.2M/ day
52-Week Range$12.73 — $39.89
LowCurrent: $15.43High

Loading 10-year price history...

RARE Historical Performance

1 YearTotal Return
-50.1%
Price: -50.1%
3 YearsTotal Return
-59.2%
CAGR: -25.8%
Price: -59.2%
5 YearsTotal Return
-81.3%
CAGR: -28.5%
Price: -81.3%
YTD
-34.6%

RARE Annual Returns

Year-by-year price performance · 2014–2026

Best+221.1%2020
Worst-45.1%2022
Up years5/13
2014+3.9%
2015+141.8%
2016-31.0%
2017-33.7%
2018-11.8%
2019+2.4%
2020+221.1%
2021-38.4%
2022-45.1%
2023+5.1%
2024-12.7%
2025-44.1%
2026-34.4%
2014 annual price return
+3.9%
2015 annual price return
+141.8%
2016 annual price return
-31.0%
2017 annual price return
-33.7%
2018 annual price return
-11.8%
2019 annual price return
+2.4%
2020 annual price return
+221.1%
2021 annual price return
-38.4%
2022 annual price return
-45.1%
2023 annual price return
+5.1%
2024 annual price return
-12.7%
2025 annual price return
-44.1%
2026 annual price return
-34.4%
LessMore
Alpha vs S&P 500
1Y-59.8%
3Y-44.6%
5Y-37.8%

Price returns only.

Download Historical Data

3,212 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

RARE Stock Price Trajectory (2014–2026)

As of November 8, 2026, Ultragenyx Pharmaceutical Inc. (RARE) trades at $15.43, representing a -50.1% return over the past year. The stock has delivered a -81.3% total return over five years (-28.5% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $179.65 on December 24, 2020. From this peak, RARE has corrected -91.4%, currently trading 32% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers BMRN (+8.1% 1Y), SRPT (+1.0% 1Y), and IONS (-46.8% 1Y), RARE has underperformed the peer group average. Compare RARE vs BMRN →

RARE Historical Price Data · from 2014

Rows 1–50 of 3,212
Date Open High Low Close Volume Change %
2026-11-0615.6815.9715.1215.434.05M-0.90%
2026-11-0517.0717.1215.4915.575.39M-9.27%
2026-11-0417.0417.6716.2317.167.51M+3.19%
2026-11-0316.5216.9916.3816.633.71M+2.02%
2026-11-0216.2916.4415.8516.304.84M+1.24%
2026-10-3016.6416.9315.9216.102.33M-4.05%
2026-10-2917.2617.6316.7116.782.80M-2.44%
2026-10-2816.7317.3516.4717.202.32M+2.69%
2026-10-2716.0516.9615.8816.754.94M+4.17%
2026-10-2615.7516.2215.5916.083.02M+2.75%
2026-10-2315.9215.9415.4915.651.79M-1.88%
2026-10-2215.7816.2515.6015.952.37M+0.19%
2026-10-2116.0216.3115.7915.922.83M-0.62%
2026-10-2015.0116.2714.9916.023.55M+6.30%
2026-10-1914.6715.0814.5415.072.98M+3.65%
2026-10-1615.1115.2114.4414.542.93M-4.15%
2026-10-1514.8715.3714.7915.173.33M+1.81%
2026-10-1414.9315.1814.6714.902.96M-0.13%
2026-10-1315.2715.3914.6914.925.31M-2.48%
2026-10-1215.4215.4915.1015.302.90M-1.16%
2026-10-0915.3015.7315.2315.482.93M+1.24%
2026-10-0814.7915.5214.4315.295.40M+2.69%
2026-10-0714.3715.2514.3514.894.16M+2.97%
2026-10-0614.6014.7014.0814.463.89M-0.28%
2026-10-0515.2515.3114.2114.504.66M-4.73%
2026-10-0214.9015.2814.6715.223.88M+3.19%
2026-10-0115.0315.2514.6214.754.12M-1.86%
2026-09-3015.4815.5314.8615.034.42M-1.89%
2026-09-2914.4615.5014.1115.325.88M+6.32%
2026-09-2814.3314.4714.1114.414.94M-0.62%
2026-09-2514.8714.9414.1514.504.31M-1.83%
2026-09-2414.7314.8714.5514.773.49M-0.74%
2026-09-2315.4015.5014.5414.885.71M-4.74%
2026-09-2214.7816.1214.4815.628.13M+6.62%
2026-09-2114.5815.0114.2814.655.27M+0.96%
2026-09-1814.7915.0714.0714.5113.34M+0.07%
2026-09-1713.2214.5813.2014.5012.43M+12.58%
2026-09-1613.0713.2212.7312.885.03M-1.45%
2026-09-1513.5613.5912.8813.075.66M-3.97%
2026-09-1414.4414.4413.6013.615.93M-4.83%
2026-09-1114.4314.7014.1314.303.25M-0.69%
2026-09-1014.2514.4413.9514.403.67M+0.63%
2026-09-0914.7715.1914.2714.314.58M-3.83%
2026-09-0815.1015.2514.6314.885.93M-2.75%
2026-09-0415.4816.0815.2315.3011.49M+3.03%
2026-09-0314.0015.0013.8114.8527.16M-44.03%
2026-09-0225.9626.8025.5726.537.17M+2.79%
2026-09-0125.2225.8525.1125.811.87M+2.38%
2026-08-3125.4525.9024.7325.211.93M-1.56%
2026-08-2826.5426.7325.3725.611.61M-2.48%
…
Consensus & Technical Research Suite
Open RARE Terminal

RARE Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

RARE — Frequently Asked Questions

Quick answers to the most common questions about buying RARE stock.

How has RARE stock performed recently?

RARE declined -50.1% over the past year, below its 5-year annualized CAGR of -28.5%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is RARE's all-time high price?

Ultragenyx Pharmaceutical Inc. reached $179.65 on 2020-12-24. The 52-week high is $39.89. Current 1-year return of -50.1% places the stock further from historical peaks.

Where can I download RARE historical price data?

This page provides RARE daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

460 data points · sampled from 3,212